Fermenta Biotech Documenti
Documenti
0
Ticker
506414.BO
ISIN
INE225B01021
Fermenta Biotech SEC Filings
Tipo | Rapporto | Data |
|---|---|---|
| Nessun documento disponibile | ||
Fermenta Biotech Documenti 2026
Questa pagina contiene tutti i documenti ufficiali e i filing SEC dell'azione Fermenta Biotech (506414.BO, ISIN: INE225B01021). Sono incluse le relazioni annuali (Form 10-K), le relazioni trimestrali (Form 10-Q) e le transazioni degli insider (Form 4). Attualmente sono disponibili 0 documenti. I dati vengono aggiornati regolarmente per offrire agli investitori una panoramica completa dei depositi regolamentari di Fermenta Biotech.
Fermenta Biotech Analisi delle Azioni
Fermenta Biotech Fermenta Biotech Ltd is a pharmaceutical company headquartered in Thane, India, listed on the stock exchange on 4 January 1990. With a workforce of 550 employees, the firm operates primarily in the manufacturing and supply of Vitamin D3 and other bulk drugs. Its Chemicals and Bulk Drug segment produces enzymes and specialized technologies for the biopharmaceutical life cycle, serving industries such as pharmaceuticals, animal feed, and food fortification. Additionally, the company offers nutritional ingredients like fish oil-derived cholesterol and natural astaxanthin. The Property segment complements these operations by managing the renting and sale of real estate assets.